Stock Earnings

Question 1

What are Eli Lilly and Co's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Eli Lilly and Co has a total asset of $112,476, Net profit of $20,640

Question 2

What are the key financial ratios for LLY?

Accepted Answer

Eli Lilly and Co's Current ratio is 1.3, has a Net margin is 31.66, sales per share of $72.47.

Question 3

How is Eli Lilly and Co's revenue broken down by segment or geography?

Accepted Answer

Eli Lilly and Co largest revenue segment is Glucagon, at a revenue of 32,500,000 in the most earnings release.For geography, US Revenue is the primary market for Eli Lilly and Co, at a revenue of 43,481,000,000.

Question 4

Is Eli Lilly and Co profitable?

Accepted Answer

yes, according to the latest financial statements, Eli Lilly and Co has a net profit of $20,640

Question 5

Does Eli Lilly and Co have any liabilities?

Accepted Answer

yes, Eli Lilly and Co has liability of 85,941

Question 6

How many outstanding shares for Eli Lilly and Co?

Accepted Answer

Eli Lilly and Co has a total outstanding shares of 944.8

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	72,249	65,179	45,042	34,124	28,541	28,318
Revenue Growth (YoY)	47%	45%	32%	20%	1%	15%
Cost of Revenue	12,404	11,052	8,418	7,082	6,629	7,312
Gross Profit	59,844	54,127	36,624	27,041	21,911	21,005
Selling, General & Admin	11,559	11,094	8,593	7,403	6,440	6,431
Research & Development	14,113	13,337	10,990	9,313	7,190	7,025
Operating Expenses	25,672	24,431	19,584	16,716	13,631	13,457
Other Non Operating Income (Expenses)	-397	-571	436	429	358	341
Pretax Income	31,125	25,731	12,680	6,554	6,806	6,155
Income Tax Expense	5,848	5,091	2,090	1,314	561	573
Net Income	25,276	20,640	10,590	5,240	6,244	5,581
Net Income Growth	128%	95%	102%	-16%	12%	-10%
Shares Outstanding (Diluted)	895.9	899.3	904.05	903.28	904.61	911.68
Shares Change (YoY)	-1%	-1%	0%	0%	-1%	0%
EPS (Diluted)	28.21	22.95	11.71	5.8	6.9	6.12
EPS Growth	129%	96%	102%	-16%	13%	-10%
Free Cash Flow	10,367	5,964	414	-3,152	4,600	5,387
Free Cash Flow Per Share	11.57	6.63	0.45	-3.48	5.08	5.9
Gross Margin	82.83%	83.04%	81.31%	79.24%	76.77%	74.17%
Operating Margin	47.29%	45.56%	37.83%	30.25%	29.01%	26.65%
Profit Margin	34.98%	31.66%	23.51%	15.35%	21.87%	19.7%
Free Cash Flow Margin	14.34%	9.15%	0.91%	-9.23%	16.11%	19.02%
EBITDA	36,215	31,693	18,806	11,852	9,802	9,095
EBITDA Margin	50.12%	48.62%	41.75%	34.73%	34.34%	32.11%
D&A For EBITDA	2,043	1,997	1,766	1,527	1,522	1,547
EBIT	34,172	29,696	17,040	10,325	8,280	7,548
EBIT Margin	47.29%	45.56%	37.83%	30.25%	29.01%	26.65%
Effective Tax Rate	18.78%	19.78%	16.48%	20.04%	8.24%	9.3%

Eli Lilly and Co (LLY) Price

LLY Stock Price Chart

LLY Income

Follow-Up Questions